Gut Microbial Control of Neurotransmitters and Their Relation to Neurological Disorders: A Comprehensive Review
Hormone and Metabolic Research · 01.05.2025 · 57 (05) · 315-325
DOI: 10.1055/a-2536-1421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.05.2025. Verfasst von Kajal Gurow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gurukul Pharmacy College IPB-13, RIICO Industrial Area, Ranpur, Kota, Rajasthan, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Neurotransmitter Agents, Nervous System Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
The study explores the vital role of gut microbiota in regulating neurotransmitters and its subsequent effects on brain function and mental health. It aims to unravel the mechanisms by which microbial metabolites influence neurotransmitter synthesis and signaling. The ultimate goal is to identify potential therapeutic strategies targeting gut microbiota for the management and treatment of neurological disorders, such as depression, autism spectrum disorder (ASD), anxiety, and Parkinson’s disease. The review synthesizes current research on the gut-brain axis, focusing on the influence of gut microbial metabolites on key neurotransmitters, including dopamine, serotonin, and gamma-aminobutyric acid (GABA). It incorporates a multidisciplinary approach, linking microbiology, neurobiology, and clinical research. Each section presents an in-depth review of scientific studies, clinical trials, and emerging therapeutic strategies. The findings highlight the intricate interplay between gut microbiota and the central nervous system. Gut microbes significantly impact the synthesis and signaling of crucial neurotransmitters, which play a pivotal role in neurological health. Evidence supports the hypothesis that modulating gut microbiota can alter neurotransmitter output and alleviate symptoms associated with neurological disorders. Notable therapeutic potentials include microbiota-targeted interventions for managing depression, ASD, anxiety, and Parkinson's disease. This comprehensive analysis underscores the critical connection between gut microbiota and neurological health. By bridging gaps between microbiology, neurobiology, and clinical practice, the study opens avenues for innovative therapeutic approaches. It provides a valuable resource for researchers, clinicians, and students, emphasizing the need for continued investigation into gut microbiota’s role in neurological disorders and its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gurukul Pharmacy College IPB-13, RIICO Industrial Area, Ranpur, Kota, Rajasthan, India.
- Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandar Sindri, Dist. Ajmer, Rajasthan, India.
- Department of Pharmacy, Graphic Era Hill University, Bhimtal, India.
- Faculty of Pharmaceutical Sciences, Amrapali University, Haldwani, India.
ORCID-Profile: Deepak Chandra Joshi
Zitieren
APA
Gurow, K., Joshi, D. C., Gwasikoti, J., & Joshi, N. (2025). Gut Microbial Control of Neurotransmitters and Their Relation to Neurological Disorders: A Comprehensive Review. Hormone and Metabolic Research, 57(05), 315-325. https://doi.org/10.1055/a-2536-1421
Vancouver
Gurow K, Joshi DC, Gwasikoti J, Joshi N. Gut Microbial Control of Neurotransmitters and Their Relation to Neurological Disorders: A Comprehensive Review. Hormone and Metabolic Research. 2025;57(05):315-325. doi:10.1055/a-2536-1421
BibTeX
@article{Gurow2025,
author = {Gurow, Kajal and Joshi, Deepak Chandra and Gwasikoti, Jyoti and Joshi, Nirmal},
title = {Gut Microbial Control of Neurotransmitters and Their Relation to Neurological Disorders: A Comprehensive Review},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {05},
pages = {315--325},
doi = {10.1055/a-2536-1421}
}
EUVIMED